1. 1 DRUG-FREE WORKPLACE PROGRAM The Trade Show/Production Industry Labor and Management partnership to address the problems caused by drug and alcohol in the workplace. Sponsored By Trade Show/Production Employers & USW # 17 Administered by ScreenSafe, Inc.

2. 2 Goals and Objectives Recognition of the problem; Development of a comprehensive policy; Educate Individuals; Promote the Member/Employee Assistance Program, MAP/EAP; Implement a fair and respectful drug testing program that conforms to Federal drug testing standards.

3. 3 Policy Requirements and Prohibitions The use of alcohol or drugs by employees during working hours on the job site or on company property (including company vehicles) is absolutely prohibited. Individuals are required to submit to drug and/or alcohol testing in accordance with this policy.

4. 4 Policy Requirements and Prohibitions No individual will be tested for alcohol unless a reasonable suspicion exists that the person is under the influence of alcohol, or they are involved in an recordable on the job accident. Participants will be required to take an alcohol test by way of evidential breath testing device (breathalyzer). Individuals subject to this policy continue to have access to the usual protections provided as part of their union membership.

5. 5 Policy Requirements and Prohibitions All USW # 17 Local members/participants will be subject to this program. Individuals will be selected randomly from the 10% pool each year. At the same time there will be an ongoing 5% pool.

6. 6 Testing Procedures Names picked from the random pool. ScreenSafe refers to the union to find where union member is working. Designated (Company or Union) Representative is called and informed to expect a fax/email regarding individuals being tested.

7. 7 Testing Procedures ScreenSafe makes calls to Designated Representative in the AM. Designated Representative faxes/emails Notification Form back to ScreenSafe

8. 8 Testing Procedures Forms sent to Designated Representative: Trade Show/Production Industry Drug-Free Alliance Program Information Sheet Trade Show/Production Industry Drug-Free Alliance Program Information Sheet Employee Notification Form Employee Notification Form

9. 9 Testing Procedures By the end of the business day, the Designated Representative informs Individual that his/her name has been selected. Individuals will either be taken directly to the collection site by the employer or are given until end of next day to take test. Individuals are given one hour with regular pay and fringe benefits by the employer who notified him/her to test.

10. 10 Testing Procedures - Safeguards All testing sites are DHHS approved Integrity of specimens insured by utilization of one collection procedure at all sites All labs have DHHS certification and are NIDA approved All positives confirmed by GC/MS MRO reviews all drug test positives

11. Finding a Collection Facility www.screensafeinc.com Click on Find a Location Enter Zipcode or City and State Call ScreenSafe 877-727-3369 11

12. 12

13. 13 At The Collection Site  The Alliance Drug Test Information and Instruction Sheet  Authorization for Consent to Drug Analysis and Authorization of Release of Results for Testing  Release of Information Signed for MRO, MAP and ScreenSafe

14. 14 At The Collection Site  Participant states they are from Local 17 Decorators  Participant must have a valid picture ID(MPA Photo ID will work with another form of ID)  Participant signs consent forms  Collection Site technician faxes Consent and Release form back to ScreenSafe.

15. 15 Testing Procedures – Safeguards Urine samples separated into two containers at time of collection Other forms of testing for Individuals with confirmed medical conditions Blind testing

16. 16 Testing Procedures If the test is negative, no further action is taken. If the test is positive, the Medical Review Officer (MRO) calls individual to validate reason for positive. If no valid reason found, the individual is in violation of policy.

17. 17 Medical Review Office  Verifies your prescription  It must be your prescription and must have been filled before the date of your test.  If your prescription is verified by the MRO a negative result is reported out.  Any participant can call the MRO to try to verify a result.  Any participant can re-test the ORIGINAL specimen at a substantial cost. If the re-tested specimen is negative the participant will be refunded. re-tested specimen is negative the participant will be refunded.

18. 18 Testing Procedures Testing will also be done when there is “reasonable suspicion”. Accelerated testing (follow-up) takes place (based on MAP/EAP recommendation) once a Individual is non-compliant and has returned to work.

19. 19 Policy Violations Policy Violations can include; Having a positive test result. Having a positive test result. Failing to take a test as scheduled Failing to take a test as scheduled Failing to keep a scheduled appointment with MAP/EAP or Failing to keep a scheduled appointment with MAP/EAP or Failing to participate in and/or complete the assigned treatment or education program Failing to participate in and/or complete the assigned treatment or education program

20. 20 Policy Violations Policy Violations can include (continued); Substituting another substance or specimen Substituting another substance or specimen Providing a dilute specimen for a second time without a valid medical explanation Providing a dilute specimen for a second time without a valid medical explanation Providing a urine specimen which shows the presence of an adulterant Providing a urine specimen which shows the presence of an adulterant

21. 21Consequences Upon a first positive test; Individual will be referred to the EAP for evaluation Individual will be referred to the EAP for evaluation Individual must begin recommended treatment or education program Individual must begin recommended treatment or education program Individual will mostly be returned to work prior to program completion Individual will mostly be returned to work prior to program completion The Individual will be placed in a one year accelerated testing program. If the individual decides not to follow the MAP recommendations, on the first non-compliant the individual may wait out 30 days and retest with a negative drop. During the 30 day wait out the individual can not be worked by a contractor and ineligible for referral.

22. 22Consequences Upon a second positive test; Individual will be referred to the MAP for evaluation Individual will be referred to the MAP for evaluation Individual must begin recommended treatment or education program Individual must begin recommended treatment or education program Individual will be placed in a one year accelerated testing program. Individual must sign a “Last Chance Agreement” between him/herself, the Alliance and the Union or Contractor.

23. 23Consequences Upon a third positive test within a two-year period from the preceding (second); Individual will be discharged from the Union Individual will be discharged from the Union

24. 24 Consequence Procedures ScreenSafe informs Designated Representative from the employer Designated Representative from the employer Designated Representative for the Local Designated Representative for the Local Individual must be removed from the worksite immediately Individual must be removed from the worksite immediately Individual can not return until they receive a release from ScreenSafe. Individual can not return until they receive a release from ScreenSafe. Individuals will receive written notice confirming their non-compliance and providing them with information to assist them in returning to compliance.

25. 25 Post-Accident Testing Post accident testing may be done when employees are involved in a recordable on the job accident. When Post Accident testing is done the employer is entitled to the results.

26. 26 Testing Procedures- Reasonable suspicion/for cause  A supervisor calls Screensafe for paperwork and procedure.  A supervisor must confront you.  A supervisor must drive you to the test site.  A supervisor must find a way home for you.  The designated representative is notified of result.  If a participant is negative any lost wages are reimbursed.  If the participant is positive you are considered non-compliant.

27. The act gives protection against criminal prosecution for the possession and use of Medical Cannabis as long as the Act is followed within the State of Illinois. Medically Legal in Illinois What Does It Really Mean! 27 Medical Marijuana

28. Simple answer YES, Under federal law marijuana and the active ingredient Delta-9- Tetrahydrocannabinol (THC) is still considered a Schedule 1 drug under the Controlled Substances Act. Simple answer YES, Under federal law marijuana and the active ingredient Delta-9- Tetrahydrocannabinol (THC) is still considered a Schedule 1 drug under the Controlled Substances Act. That means: That means: The drug or other substance has a high potential for abuse. The drug or other substance has a high potential for abuse. The drug or other substance has no currently accepted medical use in treatment in the United States. The drug or other substance has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use of the drug or other substance under medical supervision. There is a lack of accepted safety for use of the drug or other substance under medical supervision. But It’s Still Illegal Under Federal Law, and That Trumps State Law Right? 28

29. Let’s be clear there is no legal prescription for Marijuana. Let’s be clear there is no legal prescription for Marijuana. Because marijuana is still a schedule 1 drug there is no legal prescription anywhere in the United States. Because marijuana is still a schedule 1 drug there is no legal prescription anywhere in the United States. A doctor can recommend the medical use of marijuana in compliance with the Act because of their first amendment right. A doctor can recommend the medical use of marijuana in compliance with the Act because of their first amendment right. 29 But I have a Prescription for Marijuana?

30. Marinol is a synthetic form of THC that some doctors prescribe for patients with cancer, the affects are supposed to be an appetite increaser and nausea deterrent without the psychological/mental affects marijuana has on a person. Marinol is a synthetic form of THC that some doctors prescribe for patients with cancer, the affects are supposed to be an appetite increaser and nausea deterrent without the psychological/mental affects marijuana has on a person. Yes, there is a legal prescription for Marinol. Yes, there is a legal prescription for Marinol. If a participant tests positive for THC and has a valid Marinol prescription we can test the specimen to see if they only tested for the synthetic form of THC that it is Marinol or if the participant is also smoking or ingesting marijuana. If a participant tests positive for THC and has a valid Marinol prescription we can test the specimen to see if they only tested for the synthetic form of THC that it is Marinol or if the participant is also smoking or ingesting marijuana. 30 What about Marinol?

31. Medical Marijuana At this point no one under the Alliance Program can have a certification from the State of Illinois and use that certification as a reason for testing positive on a drug screen. 31

32. Questions 32